Vaccines, Blood & Biologics

ESPEROCT

STN: BL 125671
Proper Name: Antihemophilic Factor (Recombinant), GlycoPEGylated-exei
Tradename: ESPEROCT
Manufacturer: Novo Nordisk, Inc.
Indication: 

  • For use in adults and children with hemophilia A for: (1) on-demand treatment and control of bleeding episodes, (2) perioperative management of bleeding, and (3) routine prophylaxis to reduce the frequency of bleeding episodes.

 

More in Vaccines, Blood & Biologics

Page Last Updated: 03/15/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English